IDT Biologika
Dedicated to Contract Development and Manufacturing of
Viral Vaccines, Viral Vectors and Biologics

IDT Biologika specializes in the contract development and manufacturing of Viral Vaccines, Gene and Immunotherapeutics as well as sterile liquids and lyophilized Biologics. We help biopharmaceutical and biotech companies as well as the US government as part of research consortia with the challenging and complex process of translating viral vaccines and biopharmaceuticals from the research lab through clinical development to large-scale commercial manufacturing including drug substance production, fill & finish, packaging and analytics. IDT Biologika provides fully integrated services for GMP compliant end-to-end services in BSL2 facilities meeting EMA, FDA and ANVISA standards.

We strive for strong, trusting and enduring customer partnerships. Our almost 100 year tradition in manufacturing vaccines and biopharmaceuticals motivates and obligates us to advance our clients’ products to prevent and treat diseases that impact the health of people worldwide.

Our Awards

CMO Leadership Award

2020

PharmaTech Outlook

2020

Focus Innovation Award

2020

Twitter
@IDT Biologika

Tuesday, 24. November 2020

Federal Minister @jensspahn, who visited IDT Biologika together with Prime Minister @reinerhaseloff, praised the pe… https://t.co/SemdJX9hYA more info

Monday, 23. November 2020

RT @BMG_Bund: Die deutsche Firma @idtbiologika forscht an einem Corona-Impfstoff, der - wenn alles gut geht - nächstes Jahr auf dem Markt k… more info

Monday, 23. November 2020

RT @BMG_Bund: "Ich bin überzeugt, wenn wir gemeinsam diesen schwierigen Corona-Winter hinter uns gebracht haben, wird auch die Bereitschaft… more info

Monday, 23. November 2020

RT @sachsenanhalt: Bundesminister @jensspahn hob das große Engagement von @idtbiologika hervor. „IDT ist ein international anerkanntes Unte… more info

Monday, 23. November 2020

RT @sachsenanhalt: Bundesgesundheitsminister @jensspahn und MP @reinerhaseloff besuchen zur Stunde den Impfstoffhersteller @idtbiologika in… more info

Friday, 20. November 2020

Batches of the investigational #COVID19 #vaccine candidate of the Janssen Pharma Companies of Johnson & Johnson hav… https://t.co/Up0XJB6PY7 more info

Friday, 13. November 2020

RT @EP_BioMan: Thank you for partnering with #BMWS20, @idtbiologika - https://t.co/FdoR7QMq1c. IDT Biologika specializes in the production… more info

Thursday, 12. November 2020

Join us at the BioManufacturing World Summit virtual event on November 16-17. Meet with IDT to discuss your potenti… https://t.co/LvDgwcyARt more info

Thursday, 5. November 2020

With #COVID19, there’s a high demand for #vaccines capacities, and quality requirements set and focusing resources… https://t.co/9EL31QnFFL more info

Federal Minister of Health visits IDT Biologika

Tuesday, 24. November 2020

5 million vaccine doses against COVID-19 more info

IDT Biologika receives official notification of funding from the Federal government

Thursday, 8. October 2020

IDT Biologika receives official notification of funding from the Federal government more info

SARS-CoV-2: IDT Biologika fills vaccine candidate

Wednesday, 29. July 2020

Clinical phase about to begin more info

Deputy leader of the parliamentary FDP visits IDT Biologika

Friday, 10. July 2020

Battle against SARS-CoV-2 at the heart of Germany more info

Positive interim summary of strategic realignment at CPhl trade fair:

Tuesday, 5. November 2019

IDT Biologika expands portfolio of viral vaccines and biologics more info